Assets Current assets: Cash and marketable securities Accounts receivable Inventory Total Fixed assets: Gross plant and...

Transcribed Image Text:

Assets Current assets: Cash and marketable securities Accounts receivable Inventory Total Fixed assets: Gross plant and equipment Less: Accumulated depreciation Net plant and equipment Other long-term assets Total Total assets VALIUM'S MEDICAL SUPPLY CORPORATION Balance Sheet as of December 31, 2024 and 2023 (in millions of dollars) 2024 2023 Liabilities and Equity 2024 2023 Current liabilities: $ 73 $ 72 Accrued wages and taxes $ 52 $ 42 194 182 Accounts payable 154 142 314 292 Notes payable 132 132 $ 581 $ 546 Total $ 338 $ 316 Long-term debt $ 572 $ 558 $ 1,076 $ 884 148 114 Stockholders' equity: Preferred stock (6 thousand shares) $ 6 $ 6 $ 928 136 $ 770 $ 1,064 136 $ 906 Common stock and paid-in surplus (100 thousand shares) Retained earnings 120 120 609 452 Total $ 735 $ 578 $ 1,645 $ 1,452 Total liabilities and equity $ 1,645 $ 1,452 VALIUM'S MEDICAL SUPPLY CORPORATION Income Statement for Years Ending December 31, 2024 and 2023 (in millions of dollars) Net sales Less: Cost of goods sold Gross profits Less: Other operating expenses Earnings before interest, taxes, depreciation, and amortization (EBITDA) Less: Accumulated depreciation Earnings before interest and taxes (EBIT) Less: Interest Earnings before taxes (EBT) Less: Taxes Net income Less: Preferred stock dividends Net income available to common stockholders Less: Common stock dividends Addition to retained earnings Per (common) share data: Earnings per share (EPS) Dividends per share (DPS) Book value per share (BVPS) Market value (price) per share (MVPS) Prepare a statement of cash flows for Valium's Medical Supply Corporation. 2024 $ 894 2023 $ 804 390 353 $ 504 $ 451 48 42 $ 456 34 $ 422 49 $ 409 32 $ 377 $ 373 78 $ 295 $ 6 $ 289 43 $ 334 70 $ 264 $ 6 $ 258 132 132 $ 157 $ 126 $ 2.89 $ 2.58 $ 1.32 $ 1.32 $ 7.29 $ 5.72 $ 8.32 $ 6.20 Statement of Cash Flows for Year Ending December 31, 2024 (in millions of dollars) Cash flows from operating activities Net income Additions (sources of cash): Depreciation and amortization Increase in accrued wages and taxes Subtractions (uses of cash): Net cash flow from operating activities Cash flows from investing activities Subtractions: Net cash flow from investing activities Cash flows from financing activities Additions: Note: Enter your answers in millions of dollars. Amounts to be deducted should be indicated with a minus sign. DROP DOWN IVENO OPTIONS POR BALANCE SHI Increase in Iventory Increase in long-term debt Increase in notes payable Increase in other long-term assests Perferred stock dividends Common stock dividends Deprectition and amortization Increase in accounts payable Increase in accounts revceivable Increase in accrued wages and taxes Increase in fixed assets Subtractions: $ 295 34 12 $ (192) $ (192) Net cash flow from financing activities Net change in cash and marketable securities $ Assets Current assets: Cash and marketable securities Accounts receivable Inventory Total Fixed assets: Gross plant and equipment Less: Accumulated depreciation Net plant and equipment Other long-term assets Total Total assets VALIUM'S MEDICAL SUPPLY CORPORATION Balance Sheet as of December 31, 2024 and 2023 (in millions of dollars) 2024 2023 Liabilities and Equity 2024 2023 Current liabilities: $ 73 $ 72 Accrued wages and taxes $ 52 $ 42 194 182 Accounts payable 154 142 314 292 Notes payable 132 132 $ 581 $ 546 Total $ 338 $ 316 Long-term debt $ 572 $ 558 $ 1,076 $ 884 148 114 Stockholders' equity: Preferred stock (6 thousand shares) $ 6 $ 6 $ 928 136 $ 770 $ 1,064 136 $ 906 Common stock and paid-in surplus (100 thousand shares) Retained earnings 120 120 609 452 Total $ 735 $ 578 $ 1,645 $ 1,452 Total liabilities and equity $ 1,645 $ 1,452 VALIUM'S MEDICAL SUPPLY CORPORATION Income Statement for Years Ending December 31, 2024 and 2023 (in millions of dollars) Net sales Less: Cost of goods sold Gross profits Less: Other operating expenses Earnings before interest, taxes, depreciation, and amortization (EBITDA) Less: Accumulated depreciation Earnings before interest and taxes (EBIT) Less: Interest Earnings before taxes (EBT) Less: Taxes Net income Less: Preferred stock dividends Net income available to common stockholders Less: Common stock dividends Addition to retained earnings Per (common) share data: Earnings per share (EPS) Dividends per share (DPS) Book value per share (BVPS) Market value (price) per share (MVPS) Prepare a statement of cash flows for Valium's Medical Supply Corporation. 2024 $ 894 2023 $ 804 390 353 $ 504 $ 451 48 42 $ 456 34 $ 422 49 $ 409 32 $ 377 $ 373 78 $ 295 $ 6 $ 289 43 $ 334 70 $ 264 $ 6 $ 258 132 132 $ 157 $ 126 $ 2.89 $ 2.58 $ 1.32 $ 1.32 $ 7.29 $ 5.72 $ 8.32 $ 6.20 Statement of Cash Flows for Year Ending December 31, 2024 (in millions of dollars) Cash flows from operating activities Net income Additions (sources of cash): Depreciation and amortization Increase in accrued wages and taxes Subtractions (uses of cash): Net cash flow from operating activities Cash flows from investing activities Subtractions: Net cash flow from investing activities Cash flows from financing activities Additions: Note: Enter your answers in millions of dollars. Amounts to be deducted should be indicated with a minus sign. DROP DOWN IVENO OPTIONS POR BALANCE SHI Increase in Iventory Increase in long-term debt Increase in notes payable Increase in other long-term assests Perferred stock dividends Common stock dividends Deprectition and amortization Increase in accounts payable Increase in accounts revceivable Increase in accrued wages and taxes Increase in fixed assets Subtractions: $ 295 34 12 $ (192) $ (192) Net cash flow from financing activities Net change in cash and marketable securities $